Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Pfizer Inc

(NYSE: PFE)
Add to Portfolio
+0.20 (+0.55%)
as of Oct 15, 2019

Last 36.50
Change +0.20 (+0.55%)
Open 36.45
Prev. Close 36.30
Today's Range
36.41
36.74
52wk Range
33.97
46.47
Volume 14,419,700
Avg Volume 17,914,064
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
PFE +0.55% -1.24% -15.35%
DJIA +0.89% +5.08% +7.03%
S&P 500 +1.00% +5.31% +8.90%

Key Statistics

Annual EPS 2.19
Dividend Yield 3.99%
P/E Ratio 11.76
Market Capitalization, $K 199,726,156
Weighted Alpha -19.10
Standard Deviation +0.54
Profit Margin 12.78%
Beta 0.66

Growth Rates

YTD -16.38%
1-Year -17.98%
3-Year +13.42%
5-Year +25.39%
10-Year +114.33%

Opinion

Sell Hold Buy

Recent Headlines

Look for Shares of Pfizer Inc to Potentially Pullback

Comtex SmarTrend(R) via COMTEX - Tue Oct 15, 01:06PM EDT
Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $36.41 to a high of $36.74. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $36.58 on volume of 4.9 million sha(full story)
PFE: 36.50 (+0.20)

Pfizer Inc Set to Possibly Pullback After Yesterday's

Comtex SmarTrend(R) via COMTEX - Tue Oct 15, 01:06PM EDT
Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $36.41 to a high of $36.74. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $36.58 on volume of 4.9 million sha(full story)
PFE: 36.50 (+0.20)

ImaginAb signs multi-party collaboration agreement

PR Newswire via COMTEX - Mon Oct 14, 02:00AM EDT
ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company, today announced the signing of a multi-party collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN), Pfizer Inc. (NYSE: PFE) and Takeda Pharmaceutical(full story)
AZN: 44.21 (+0.37), PFE: 36.50 (+0.20)

Pfizer Presents Positive Phase 3 Data at the 28th

BusinessWire via COMTEX - Sat Oct 12, 04:45AM EDT
---Findings follow recent positive top-line results for second abrocitinib Phase 3 pivotal study, JADE MONO-2-(full story)
PFE: 36.50 (+0.20)

SmarTrend Watching for Potential Pullback in Shares of

Comtex SmarTrend(R) via COMTEX - Fri Oct 11, 01:06PM EDT
Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $36.11 to a high of $36.58. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $36.01 on volume of 5.9 million sha(full story)
PFE: 36.50 (+0.20)